abstract |
The present invention relates to novel binding agent-prodrug conjugates (APDCs) wherein the binding agent is conjugated to an inactive precursor compound of a spindle kinesin inhibitor, and to antibody-active substance conjugate ADCs , and methods of making such APDCs or ADCs. |